# clm_ADD269D8EB64

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_revenue  
value: 5,191,700,000 United States dollar  
valid_from: 2016-09-30  
valid_to: 2017-03-31  
published: 2016-10-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_038044B3B9B8  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly revenue: 5,191,700,000 United States dollar", as of 2016-09-30 (until 2017-03-31). Claim clm_ADD269D8EB64, https://asof.is/claim/clm_ADD269D8EB64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947816000440/0000059478-16-000440-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q3 FY2016, filed 2016-10-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947816000440/0000059478-16-000440-index.htm (primary, SEC EDGAR 10-Q Q3 FY2016, published 2016-10-28)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_revenue | 5,404,800,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_ADD269D8EB64](/claim/clm_ADD269D8EB64.md) | [clm_72B1497E5670](/claim/clm_72B1497E5670.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
